-
Mashup Score: 0How Is Administrative Payment Burden Associated With Cost-Related Delays in Cancer Care - The ASCO Post - 8 month(s) ago
Research shows that the United States’ health-care delivery and financing system is so complex that streamlining administrative costs alone could reduce total health-care spending by 15%. In addition, health insurance payment and medical billing processes are time-consuming and expensive for both providers and patients. Cost-sharing between payers and patients has resulted in financial difficulties for patients, which can result in harmful cost-coping practices, such as treatment nonadherence and worse
Source: ascopost.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Chemotherapy Shortage Impacts Patients, Physicians, Costs, and Clinical Trials - The ASCO Post - 8 month(s) ago
Grim, grimmer, and grinding are among the terms reported in the press to describe the current chemotherapy shortage. 1,2 And, “it is not going away,” Mark J. Ratain, MD, FASCO, Chief Hospital Pharmacologist, University of Chicago Medicine, told The ASCO Post. “This is a progressive problem like climate change,” Dr. Ratain remarked. “It will appear on the surface to be better intermittently, as there are temporary solutions, but this is going to be a recurring problem that is not going to end until
Source: ascopost.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Overcoming Financial Toxicity From Cancer - The ASCO Post - 8 month(s) ago
I knew the moment my fingers found a lump in my left breast, in 2018, that it was cancer, and I wondered if I was going to die. My maternal grandmother had been diagnosed with breast cancer when she was 39, the same age I was when I discovered the mass in my breast. She died 5 years later. Divorced and the sole supporter and guardian of my then 15-year-old daughter, I knew that whatever this lump turned out to be, I would do everything I could to survive. After discovering the mass, I made an appointment
Source: ascopost.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Changing How Immune Checkpoint Inhibitors Are Delivered Could Reduce Costs by 14%, Study Finds - The ASCO Post - 9 month(s) ago
By The ASCO Post Staff Posted: 7/12/2023 11:44:00 AM Last Updated: 7/12/2023 1:44:47 PM Investigators have found that millions of dollars could be saved annually across the Veterans Health Administration by reconsidering how immune checkpoint inhibitors are delivered, according to a new study published by…
Source: ascopost.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Patients With Prostate Cancer May Face High Rates of Financial Toxicity - The ASCO Post - 9 month(s) ago
By The ASCO Post Staff Posted: 7/11/2023 11:19:00 AM Last Updated: 7/11/2023 1:36:52 PM About 50% of patients with metastatic prostate cancer may experience financial hardship as a result of their treatment, according to a new study published by Joyce et al in The Journal of Urology. Background “Our most…
Source: ascopost.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
By The ASCO Post Staff Posted: 4/12/2023 9:19:00 AM Last Updated: 4/12/2023 8:47:37 AM Researchers have discovered that the financial impact of an individual’s cancer diagnosis may also impact a partner’s health-related quality of life, according to a new study published by Ghazal et al in JAMA Network…
Source: ascopost.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Exploring the Economic Benefits of Biosimilars - 1 year(s) ago
April 06, 2023 33 min listen Source/Disclosures Published by: Disclosures: García and Jain report no relevant financial disclosures. ADD TOPIC TO EMAIL ALERTS Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on . We were unable to process your request. Please try…
Source: www.healio.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1Exploring the Economic Benefits of Biosimilars - 1 year(s) ago
April 06, 2023 33 min listen Source/Disclosures Published by: Disclosures: García and Jain report no relevant financial disclosures. ADD TOPIC TO EMAIL ALERTS Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on . We were unable to process your request. Please try…
Source: www.healio.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Influence of the ‘Mark Cuban Effect’ on Cancer Drug Prices in the United States: Focus on CML - The ASCO Post - 1 year(s) ago
The advent of the BCR::ABL1 tyrosine kinase inhibitors for the treatment of Philadelphia chromosome (Ph)-positive chronic myeloid leukemia (CML) was a therapeutic miracle that changed the management paradigm of CML. The first of them, imatinib, was developed in the late 1990s.1,2 Within a few years, front-line CML therapy transformed from interferon-alpha and allogeneic stem cell transplantation…
Source: ascopost.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
By Matthew Stenger Posted: 11/30/2022 10:20:00 AM Last Updated: 11/30/2022 11:22:46 AM In a retrospective cohort study reported in the Journal of Clinical Oncology, Mustafa Raoof, MD, MS, and colleagues found that California Medicare Advantage beneficiaries undergoing elective inpatient cancer surgery were…
Source: ascopost.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
How Is Administrative Payment Burden Associated With Cost-Related Delays in Cancer Care? https://t.co/iABMWSOKxh #cancercare #costofcare #treatmentdelays